Support of elexxion with a capital increase of EUR 1.8 mio
The capital increase was part of a complete debt relief from its former main shareholder L-Bank and a sale of all L-Bank shares to the management. It was supported by a new main shareholder.
As a result, elexxion is free of debt capital and is now provided with a liquidity in the amount of EUR 1.8 mio to invest in the further growth of the company.
elexxion AG (Radolfzell) is an innovative medical technology company specialised on development, production and sale of dental laser systems. The enterprise is listed as Entry Standard at the Frankfurt Stock Exchange.
December 20, 2018
Quarton International advises evitria in its sale to AFINUM and SHS
To subscribe to our Newsletter, please use the following link.